Dr. Jabbour is actively involved in developmental therapeutics research in leukemia. He is leading MD Anderson's efforts to test triple therapy in AML (nucleoside analogs + anthracyclines + cytarabine).
Get the latest thought leadership on AML delivered straight to your inbox.
Subscribe to the weekly "HealthTree Community for AML Newsletter" for AML news, life
AML stories, AML clinical trials, AML 101 articles and events with AML
Thanks to our HealthTree Community for AML Sponsors: